Keyphrases
Guinea-Bissau
100%
Bacillus Calmette
100%
Out-of-hospital Cardiac Arrest
100%
Register Study
93%
Vaccination
83%
Confidence Interval
76%
Randomized Trial
75%
Randomized Clinical Trial
71%
BCG Vaccine
66%
Cluster Randomized Trial
66%
Intensive Care Unit
66%
Non-specific Effects of Vaccines
66%
Mortality Prediction
66%
Odds Ratio
64%
Non-specific Effects
62%
Case-crossover
55%
Risk Factors
53%
Measles Virus
53%
Atopic Dermatitis
52%
Hospitalization
50%
Childhood Vaccination
44%
External Validation
37%
Vaccination Program
36%
Measles Vaccination
35%
Development Validation
33%
Hand Eczema
33%
Infant Mortality
33%
Exposure History
33%
Clinical Prediction Rule
33%
Healthcare Workers
33%
Penicillin V
33%
Management Guidelines
33%
Zanzibar
33%
Structured Interview
33%
Associated Risk
33%
Prevalence Factors
33%
Internal Validation
33%
Triangulation
33%
Antipsychotics
33%
Marginal Structural Models
33%
Home Visits
33%
Time-varying Confounding
33%
Nationwide Registers
33%
Inception Cohort Study
33%
PartoMa
33%
Labor Management
33%
Early Preterm Infants
33%
Food Allergy
33%
Life Effects
33%
Referral Hospital
33%
Pharmacology, Toxicology and Pharmaceutical Science
Out of Hospital Cardiac Arrest
100%
Randomized Clinical Trial
77%
Measles
66%
Prevalence
43%
Cohort Study
40%
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
38%
Scar Formation
33%
Penicillin V
33%
Atopic Dermatitis
33%
Cluster Randomized Trial
33%
Food Allergy
33%
Heart Infarction
33%
Delirium
33%
Mycobacterium Bovis BCG
33%
Poliomyelitis
33%
Measles Mumps Rubella Vaccine
33%
Antidepressant
33%
Cerebrovascular Accident
33%
Macrolide
33%
Wheezing
33%
Measles Rubella Vaccine
29%
Measles Mumps Vaccine
29%
Ethinylestradiol
26%
Disease Predisposition
25%
Oral Poliomyelitis Vaccine
23%
Childhood Mortality
23%
Antipsychotic
22%
Measles Vaccine
22%
Progestin
20%
Infection
18%
Mortality Rate
16%
Retinol
16%
Medicine and Dentistry
Intensive Care Unit
100%
Randomized Clinical Trial
77%
BCG Vaccination
66%
Mycobacterium Bovis BCG
54%
Cohort Analysis
41%
Patient Referral
33%
Infant Mortality
33%
Atopic Dermatitis
33%
Food Allergy
33%
Sensitization
33%
Stillbirth
33%
Poliomyelitis
33%
Measles Vaccination
33%
Perinatal Asphyxia
33%
Cluster Randomized Trial
33%
Retinopathy of Prematurity
33%
Wheeze
33%
Infection
33%
Gestational Age
31%
Disease Predisposition
25%
Oral Poliomyelitis Vaccine
25%
Diseases
25%
Measles Vaccine
18%
Tetanus
16%
Measles Mumps Rubella Vaccine
16%
Haemophilus Influenzae Type B Vaccine
16%
Haemophilus Influenzae Type B
16%
Diphtheria
16%
Pertussis
16%
Neonatal Infant
15%
